1. Home
  2. RDN vs BLCO Comparison

RDN vs BLCO Comparison

Compare RDN & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDN
  • BLCO
  • Stock Information
  • Founded
  • RDN 1977
  • BLCO 1853
  • Country
  • RDN United States
  • BLCO Canada
  • Employees
  • RDN N/A
  • BLCO N/A
  • Industry
  • RDN Property-Casualty Insurers
  • BLCO Ophthalmic Goods
  • Sector
  • RDN Finance
  • BLCO Health Care
  • Exchange
  • RDN Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • RDN 4.5B
  • BLCO 4.9B
  • IPO Year
  • RDN 1992
  • BLCO 2022
  • Fundamental
  • Price
  • RDN $35.48
  • BLCO $14.93
  • Analyst Decision
  • RDN Hold
  • BLCO Hold
  • Analyst Count
  • RDN 5
  • BLCO 11
  • Target Price
  • RDN $36.20
  • BLCO $15.80
  • AVG Volume (30 Days)
  • RDN 978.5K
  • BLCO 943.3K
  • Earning Date
  • RDN 07-30-2025
  • BLCO 07-30-2025
  • Dividend Yield
  • RDN 2.88%
  • BLCO N/A
  • EPS Growth
  • RDN 3.12
  • BLCO N/A
  • EPS
  • RDN 3.96
  • BLCO N/A
  • Revenue
  • RDN $1,285,836,000.00
  • BLCO $4,891,000,000.00
  • Revenue This Year
  • RDN N/A
  • BLCO $7.10
  • Revenue Next Year
  • RDN $2.29
  • BLCO $5.50
  • P/E Ratio
  • RDN $8.96
  • BLCO N/A
  • Revenue Growth
  • RDN 0.32
  • BLCO 8.81
  • 52 Week Low
  • RDN $29.32
  • BLCO $10.45
  • 52 Week High
  • RDN $36.99
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • RDN 61.68
  • BLCO 64.22
  • Support Level
  • RDN $34.44
  • BLCO $14.24
  • Resistance Level
  • RDN $35.03
  • BLCO $14.80
  • Average True Range (ATR)
  • RDN 0.53
  • BLCO 0.44
  • MACD
  • RDN 0.16
  • BLCO 0.05
  • Stochastic Oscillator
  • RDN 96.11
  • BLCO 92.72

About RDN Radian Group Inc.

Radian Group Inc is engaged in mortgage and real estate services. It provides both credit-related mortgage insurance coverage and other products and services across the residential real estate and mortgage finance industries. It has one business segment Mortgage Insurance. The Mortgage Insurance segment aggregates, manages, and distributes U.S. mortgage credit risk for the benefit of mortgage lending institutions and mortgage credit investors, through private mortgage insurance on residential first-lien mortgage loans, and also offers other credit risk management solutions, including contract underwriting, to customers. It also provides other mortgage and real estate products and services through Mortgage Conduit, Title, Real Estate Services, and Real Estate Technology businesses.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: